Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,733
Closed -$205K 570
2022
Q2
$205K Buy
3,733
+17
+0.5% +$985 0.02% 502
2022
Q1
$281K Buy
+3,716
New +$254K 0.03% 444

Other funds holding ACLS

Caprock Group's ACLS Position: Q3 2022 in Review

Caprock Group sold out of Axcelis (ACLS) in Q3 2022, closing a stake of 3,733 shares — an estimated $205K sold.

Caprock Group first reported a position in ACLS in Q1 2022 and held it in 2 quarters. The position peaked at $281K in Q1 2022. 287 funds tracked by Wall St. Rank hold ACLS as of Q3 2022.

  • Caprock Group reported no remaining Axcelis position as of Q3 2022 after selling out during the quarter.
  • Caprock Group sold 3,733 Axcelis shares in Q3 2022, an estimated $205K.
  • Caprock Group first reported a position in Axcelis in Q1 2022 and held it in 2 quarters.
  • Caprock Group's Axcelis position peaked at $281K in Q1 2022.
  • 287 funds tracked by Wall St. Rank held Axcelis as of Q3 2022.

Based on Caprock Group's 13F filing for Q3 2022, filed 7 Nov 2022.